Suppr超能文献

升级右心室起搏器为双心室起搏或传导系统起搏:系统评价和荟萃分析。

Upgrading right ventricular pacemakers to biventricular pacing or conduction system pacing: a systematic review and meta-analysis.

机构信息

National Heart and Lung Institute, Imperial College London, B Block, Hammersmith Hospital, Du Cane Road, London W12 0HS, UK.

School of Public Health, Imperial College London, London, UK.

出版信息

Europace. 2023 Mar 30;25(3):1077-1086. doi: 10.1093/europace/euac188.

Abstract

Guidelines recommend patients undergoing a first pacemaker implant who have even mild left ventricular (LV) impairment should receive biventricular or conduction system pacing (CSP). There is no corresponding recommendation for patients who already have a pacemaker. We conducted a meta-analysis of randomized controlled trials (RCTs) and observational studies assessing device upgrades. The primary outcome was the echocardiographic change in LV ejection fraction (LVEF). Six RCTs (randomizing 161 patients) and 47 observational studies (2644 patients) assessing the efficacy of upgrade to biventricular pacing were eligible for analysis. Eight observational studies recruiting 217 patients of CSP upgrade were also eligible. Fourteen additional studies contributed data on complications (25 412 patients). Randomized controlled trials of biventricular pacing upgrade showed LVEF improvement of +8.4% from 35.5% and observational studies: +8.4% from 25.7%. Observational studies of left bundle branch area pacing upgrade showed +11.1% improvement from 39.0% and observational studies of His bundle pacing upgrade showed +12.7% improvement from 36.0%. New York Heart Association class decreased by -0.4, -0.8, -1.0, and -1.2, respectively. Randomized controlled trials of biventricular upgrade found improvement in Minnesota Heart Failure Score (-6.9 points) and peak oxygen uptake (+1.1 mL/kg/min). This was also seen in observational studies of biventricular upgrades (-19.67 points and +2.63 mL/kg/min, respectively). In studies of the biventricular upgrade, complication rates averaged 2% for pneumothorax, 1.4% for tamponade, and 3.7% for infection over 24 months of mean follow-up. Lead-related complications occurred in 3.3% of biventricular upgrades and 1.8% of CSP upgrades. Randomized controlled trials show significant physiological and symptomatic benefits of upgrading pacemakers to biventricular pacing. Observational studies show similar effects between biventricular pacing upgrade and CSP upgrade.

摘要

指南建议,对于初次植入起搏器且左心室(LV)功能轻度受损的患者,应接受双心室或房室传导系统起搏(CSP)。但对于已经植入起搏器的患者,目前并无相应的推荐意见。我们对评估器械升级的随机对照试验(RCT)和观察性研究进行了荟萃分析。主要结局是左心室射血分数(LVEF)的超声心动图变化。共有 6 项 RCT(随机分配 161 例患者)和 47 项观察性研究(2644 例患者)符合分析条件,评估了升级为双心室起搏的疗效。另外,还有 8 项观察性研究(共 217 例患者)符合 CSP 升级分析条件。还有 14 项额外的研究提供了并发症数据(共 25412 例患者)。升级为双心室起搏的 RCT 显示 LVEF 改善了+8.4%,从 35.5%增至 43.9%;观察性研究显示 LVEF 改善了+8.4%,从 25.7%增至 34.1%。左束支区域起搏升级的观察性研究显示 LVEF 改善了+11.1%,从 39.0%增至 50.1%;希氏束起搏升级的观察性研究显示 LVEF 改善了+12.7%,从 36.0%增至 48.7%。纽约心脏协会(NYHA)心功能分级分别降低了-0.4、-0.8、-1.0 和-1.2 级。升级为双心室起搏的 RCT 发现明尼苏达心力衰竭评分(-6.9 分)和峰值摄氧量(+1.1 mL/kg/min)改善。这在双心室升级的观察性研究中也得到了证实(分别为-19.67 分和+2.63 mL/kg/min)。在双心室升级的研究中,气胸的平均发生率为 2%,心脏压塞为 1.4%,感染为 3.7%,平均随访时间为 24 个月。双心室升级的导线相关并发症发生率为 3.3%,CSP 升级为 1.8%。RCT 显示,将起搏器升级为双心室起搏可显著改善生理和症状。观察性研究表明,双心室起搏升级和 CSP 升级之间具有相似的效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c281/10062368/53d3fc3a20df/euac188f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验